What it is and what it is used for

for What Brivaracetam Cipla film-coated tablet is Brivaracetam Cipla film-coated tablet contains the active substance brivaracetam. It belongs to a group of medicines called 'anti-epileptics'. These medicines are used to treat epilepsy. What Brivaracetam Cipla film-coated tablet is used for

• Brivaracetam Cipla film-coated tablet is used in adults, adolescents and children from 2 years of age.
• It is used to treat a type of epilepsy that has partial seizures with or without a secondary generalisation.
• Partial seizures are fits that start by only affecting one side of the brain. These partial seizures can spread and extend to larger areas on both sides of the brain -this is called a 'secondary generalisation'.
• You have been given this medicine to lower the number of fits (seizures) you have.
• Brivaracetam Cipla film-coated tablet is used together with other medicines for epilepsy.

What you need to know before you take it

e Brivaracetam Cipla film-coated tablets Do not take Brivaracetam Cipla film-coated tablets if:

• you are allergic to brivaracetam, other similar chemical compounds as levetiracetam or piracetam or any of the other ingredients of this medicine (listed in section 6). If you are not sure, talk to your doctor or pharmacist before taking Brivaracetam Cipla film-coated tablets.

• you have ever developed a severe skin rash or skin peeling, blistering and/or mouth sores after taking Brivaracetam Cipla film-coated tablets. Serious skin reactions including Stevens-Johnson syndrome have been reported in association with brivaracetam treatment. Stop using Brivaracetam Cipla film-coated tablets and seek medical attention immediately if you notice any of the symptoms related to these serious skin reactions described in section 4. Warnings and precautions Talk to your doctor or pharmacist before taking Brivaracetam Cipla film-coated tablets if:
• You have thoughts of harming or killing yourself. A small number of people being treated with anti-epileptic medicines such as brivaracetam have had thoughts of harming or killing themselves. If you have any of these thoughts at any time, contact your doctor immediately.
• You have liver problems – your doctor may need to adjust your dose. Children Brivaracetam Cipla film-coated tablet is not recommended for use in children under 2 years of age. Other medicines and Brivaracetam Cipla film-coated tablets Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines. In particular, tell your doctor if you are taking any of the following medicines – this is because your doctor may need to adjust your Brivaracetam Cipla film-coated tablet dose:
• Rifampicin – a medicine used to treat bacterial infections.
• St John's wort (also known as Hypericum perforatum) – a herbal medicine used to treat depression and anxiety as well as other conditions. Brivaracetam Cipla film-coated tablet with alcohol
• Combining this medicine with alcohol is not recommended.
• If you drink alcohol while taking Brivaracetam Cipla film-coated tablet, the negative effects of alcohol may be increased. Pregnancy, breast-feeding Fertile women should discuss the use of contraceptives with the doctor. If you are pregnant or breast-feeding, think you may be pregnant or planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine. It is not recommended to take Brivaracetam Cipla film-coated tablets if you are pregnant, as the effects of brivaracetam on pregnancy and the unborn baby are not known. It is not recommended to breast-feed your baby while taking Brivaracetam Cipla film-coated tablets, as brivaracetam passes into breast milk. Do not stop treatment without talking to your doctor first. Stopping treatment could increase your seizures and harm your baby. Driving and using machines
• You may feel sleepy, dizzy or tired while taking Brivaracetam Cipla film-coated tablets.
• These effects are more likely at the start of the treatment or after a dose increase.
• Do not drive, cycle or use any tools or machines until you know how the medicine affects you. Brivaracetam Cipla film-coated tablet contains sodium This medicine contains less than 1 mmol sodium (23mg) per tablet, that is to say essentially 'sodium free'.

3. How to take Brivaracetam Cipla film-coated tablets Always take this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure. Other form(s) of this medicine may be more suitable for certain patients e.g. children (if tablets can not be swallowed in whole, for example); ask your doctor or pharmacist. You will take Brivaracetam Cipla film-coated tablet together with other medicines for epilepsy. How much to take Your doctor will work out the right daily dose for you. Take the daily dose in two equal divided doses, approximately 12 hours apart. Adolescents and children weighing 50 kg or more, and adults

• The recommended dose is from 25 mg to 100 mg taken twice a day. Your doctor may then decide to adjust your dose to find the best dose for you. Adolescents and children weighing from 20 kg to less than 50 kg
• The recommended dose is from 0.5 mg to 2 mg for each kg of bodyweight, taken twice a day. Your doctor may then decide to adjust your dose to find the best dose for you. Children weighing from 10 kg to less than 20 kg
• The recommended dose is from 0.5 mg to 2.5 mg for each kg of bodyweight, taken twice a day. Your child's doctor may then decide to adjust your child's dose to find the best dose for your child. People with liver problems If you have problems with your liver:
• As an adolescent or child weighing 50 kg or more, or as an adult, the maximum dose you will take is 75 mg twice a day.
• As an adolescent or child weighing from 20 kg to less than 50 kg, the maximum dose you will take is 1.5 mg for each kg of bodyweight twice a day.
• As a child weighing from 10 kg to less than 20 kg, the maximum dose your child will take is 2 mg for each kg of bodyweight twice a day.

How to take it

Brivaracetam Cipla film-coated tablets

• Swallow the tablets whole with a glass of liquid.
• The medicine may be taken with or without food. How long to take Brivaracetam Cipla film-coated tablet for Brivaracetam Cipla film-coated tablet is a long term treatment – keep taking Brivaracetam Cipla film-coated tablets until your doctor tells you to stop. If you take more Brivaracetam Cipla film-coated tablets than you should If you have taken more Brivaracetam Cipla film-coated tablets than you should, talk to your doctor. You may feel dizzy and sleepy. You may also have any of the following symptoms: feeling sick, a feeling of 'spinning', problems of keeping your balance, anxiety, feeling very tired, irritability, being aggressive, not being able to sleep, depression, thoughts or attempts of harming or killing yourself. If you forget to take Brivaracetam Cipla film-coated tablets
• If you miss a dose take it as soon as you remember.
• Then take your next dose at the time you would normally take it.
• Do not take a double dose to make up for a forgotten dose.

• If you are not sure what to do, ask your doctor or pharmacist. If you stop taking Brivaracetam Cipla film-coated tablets
• Do not stop taking this medicine unless your doctor tells you to. This is because stopping treatment could increase the number of fits you have.
• If your doctor asks you to stop taking this medicine they will lower your dose gradually. This helps to stop your fits coming back or getting worse. If you have any further questions on the use of this medicine, ask your doctor or pharmacist.

Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them. Very common: may affect more than 1 in 10 people

• feeling sleepy or dizzy Common: may affect up to 1 in 10 people
• flu
• feeling very tired (fatigue)
• convulsion, a feeling of 'spinning' (vertigo)
• feeling and being sick, constipation
• depression, anxiety, not being able to sleep (insomnia), irritability
• infections of the nose and throat (such as the 'common cold'), cough
• decreased appetite Uncommon: may affect up to 1 in 100 people
• allergic reactions
• abnormal thinking and/or loss of touch with reality (psychotic disorder), being aggressive, nervous excitement (agitation)
• thoughts or attempts of harming or killing yourself: tell your doctor straight away
• a decrease in white blood cells (called 'neutropenia') – shown in blood tests Not Known: frequency cannot be estimated from available data
• a widespread rash with blisters and peeling skin, particularly around the mouth, nose, eyes and genitals (Stevens-Johnson syndrome) Additional side effects in children Common: may affect up to 1 in 10 people
• restlessness and hyperactivity (psychomotor hyperactivity) Reporting of side effects If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via Yellow Card Scheme Website: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects, you can help provide more information on the safety of this medicine.

How to store it

Brivaracetam Cipla film-coated tablets

• Keep this medicine out of the sight and reach of children.

• Do not use this medicine after the expiry date which is stated on the carton and blister after EXP.

The expiry date refers to the last day of that month.

• This medicinal product does not require any special storage conditions.
• Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how

to throw away medicines you no longer use. These measures will help protect the environment.

Contents of the pack and other information

What Brivaracetam Cipla film-coated tablet contains

• The active substance is brivaracetam. Each film-coated tablet contains 10 mg, 25 mg, 50 mg, 75 mg, or 100 mg brivaracetam.
• The other ingredients are: Core: Croscarmellose sodium (E468); cellulose, microcrystalline (E460); starch, pregelatinized; magnesium stearate (E470b) Coating:
• 10 mg film-coated tablets: calcium carbonate (E170), macrogol (E1521), polyvinyl alcohol (E1203), talc (E553b).
• 25 mg film-coated tablets: calcium carbonate (E170), iron oxide black (E172), iron oxide yellow (E172), macrogol (E1521), polyvinyl alcohol (E1203), talc (E553b).
• 50 mg film-coated tablets: calcium carbonate (E170), iron oxide black (E172), iron oxide red (E172), iron oxide yellow (E172), macrogol (E1521), polyvinyl alcohol (E1203), talc (E553b).
• 75 mg film-coated tablets: calcium carbonate (E170), iron oxide black (E172), iron oxide red (E172), macrogol (E1521), polyvinyl alcohol (E1203), talc (E553b).
• 100 mg film-coated tablets: calcium carbonate (E170), iron oxide black (E172), iron oxide yellow (E172), macrogol (E1521), polyvinyl alcohol (E1203), talc (E553b). What Brivaracetam Cipla film-coated tablet looks like and contents of the pack Brivaracetam Cipla 10 mg film-coated tablets are white to off-white, round, biconvex film-coated tablets of 6 mm diameter debossed with "10" on one side. Brivaracetam Cipla 25 mg film-coated tablets are grey, oval, biconvex, film-coated tablets with dimensions of 9 x 5 mm debossed with "25" on one side. Brivaracetam Cipla 50 mg film-coated tablets are yellow, oval, biconvex film-coated tablets with dimensions of 12 x 7 mm debossed with "50" on one side. Brivaracetam Cipla 75 mg film-coated tablets are pink, oval, biconvex film-coated tablets with dimensions of 13 x 7 mm diameter debossed with "75" on one side. Brivaracetam Cipla 100 mg film-coated tablets are grey green, oval, biconvex filmcoated tablets with dimensions of 15 x 8 mm debossed with "100" on one side. Aluminium/Aluminium (OPA/ aluminium foil/ PVC) blister Brivaracetam Cipla film-coated tablets are packaged in blister packs supplied in cardboard boxes containing either 14, 28 or 56 film-coated tablets. 10 mg, 25 mg, 50 mg and 75 mg are also supplied in multipacks of 168 (2 packs of 84) film-coated tablets. 100 mg are also supplied in multipacks of 168 (3 packs of 56) film-coated tablets. Not all pack sizes may be marketed.

Marketing Authorisation Holder and manufacturer Cipla (EU) Limited, Dixcart House, Addlestone Road, Bourne Business Park, Addlestone, Surrey, KT15 2LE, United Kingdom This leaflet was last revised in 10.2025.